Current therapy of lupus nephritis. Which is the best option?

Renal involvement in systemic lupus erythematosus (SLE) is an important cause of morbidity and mortality, reaching a prevalence of 39% during the course of the disease. Currently, the therapy for severe lupus nephritis is based on the use of high-dose corticosteroids and immunosuppressive drugs, bei...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Revista clínica espanõla 2008-03, Vol.208 (3), p.138-141
Hauptverfasser:	Silva-Fernández, L., Andreu-Sánchez, J.L., Ginzler, E.M.
Format:	Artikel
Sprache:	spa
Schlagworte:	lupus eritematoso sistémico, nefritis lúpica, terapia, micofenolato mofetilo lupus nephritis micophenolate mofetil systemic lupus erythematosus therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!